Objective: To determine the situations of erythropoietin management of personnel at tambon, or sub-district, health promoting hospitals (SDHPHs) in Petchaburi province, Thailand. Methods: This cross-sectional survey was conducted from January to March 2017. Questionnaires were mailed to 117 SDHPHs. A director and a staff member of each SDHPH were assigned to be informants. The informants were asked about knowledge and practice on erythropoietin management. The response rate was 64.10%. Results: Most of the respondents were female (89.33%), with the average age of 42.80 years.Most of them had experience in erythropoietin management (58.67%), mostly involving in the drug management (88.00%). Most of the staff members had never been trained on...
Erythropoietin or EPO is a glycoprotein hormone that controls Erythropoiesis, or red blood cell prod...
Objective: To determine the effect of subcutaneous recombinant human erythropoietin on blood pressur...
Early dosing practices and effectiveness of recombinant human erythropoietin. In a national longitud...
Objectives. Drug utilization evaluation (DUE) studies aim to survey the appropriateness of drug use....
Objective: To compare the efficacy, safety and side effects between subcutaneous and intravenous rou...
Most of the patients with end-stage renal disease who undergo hemodialysis receive erythropoietin (E...
Introduction: Erythropoiesis Stimulating Agents contribute significantly to reduction in mortality a...
Background: Anemia is one of most common complications in end stage renal disease (ESRD) patients. E...
Background: Anaemia is a common complication of chronic kidney disease. The close relationship betwe...
Erythropoietin, produced primarily by the kidneys, is the principal factor responsible for the regul...
Background: Chronic Kidney Disease (CKD) is an abnormality of kidney in its structure and function t...
End-stage renal failure patients are normally anaemic due to failure of renal to produce endogenous ...
AbstractObjectiveTo compare the cost utility of using erythropoietin (EPO) to maintain different hem...
Experience with prevention programs in Thailand.BackgroundThailand is a developing country with a po...
The aim of this research is to investigate the health promotion services provided by district hospit...
Erythropoietin or EPO is a glycoprotein hormone that controls Erythropoiesis, or red blood cell prod...
Objective: To determine the effect of subcutaneous recombinant human erythropoietin on blood pressur...
Early dosing practices and effectiveness of recombinant human erythropoietin. In a national longitud...
Objectives. Drug utilization evaluation (DUE) studies aim to survey the appropriateness of drug use....
Objective: To compare the efficacy, safety and side effects between subcutaneous and intravenous rou...
Most of the patients with end-stage renal disease who undergo hemodialysis receive erythropoietin (E...
Introduction: Erythropoiesis Stimulating Agents contribute significantly to reduction in mortality a...
Background: Anemia is one of most common complications in end stage renal disease (ESRD) patients. E...
Background: Anaemia is a common complication of chronic kidney disease. The close relationship betwe...
Erythropoietin, produced primarily by the kidneys, is the principal factor responsible for the regul...
Background: Chronic Kidney Disease (CKD) is an abnormality of kidney in its structure and function t...
End-stage renal failure patients are normally anaemic due to failure of renal to produce endogenous ...
AbstractObjectiveTo compare the cost utility of using erythropoietin (EPO) to maintain different hem...
Experience with prevention programs in Thailand.BackgroundThailand is a developing country with a po...
The aim of this research is to investigate the health promotion services provided by district hospit...
Erythropoietin or EPO is a glycoprotein hormone that controls Erythropoiesis, or red blood cell prod...
Objective: To determine the effect of subcutaneous recombinant human erythropoietin on blood pressur...
Early dosing practices and effectiveness of recombinant human erythropoietin. In a national longitud...